UNSPSC 51111835: Benorterone
Commodity
Code facts
- Part of
-
-
51000000
-
51110000
- 51111800
-
51110000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51111835
| NIGP code |
|---|
| 26968 Hormones and Synthetic Substitutes |
Definition
This classification denotes an anti-androgen with the molecular formula C19H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J339Q7IM54, chemically known as b-norandrost-4-en-3-one, 17-hydroxy-17-methyl-, (17beta)- but generally known as benorterone, which bears US NIH Compound Identifier 19126. European Medicines Agency schedules Benorterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05723MIG. The term BENORTERONE is an International Non-Proprietary Name.
Read the full definition
BENORTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benorterone under HS 29372900 and SITC 54153. As of Q4 2014, BENORTERONE remains the US FDA Preferred Term for this commodity. Benorterone bears US NLM identifiers UMLS ID C0053110 and NCI Concept Code C74121. SMILES: OC1(C2(C(C3C(C4(C(=CC(=O)CC4)C3)C)CC2)CC1)C)C.
About UNSPSC 51111835
UNSPSC 51111835 Benorterone, a Commodity code, encompasses generic pharmaceutical products that state and local governments procure through cooperative purchasing vehicles. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, solicits under this code to stock pharmaceuticals and over-the-counter products across participating state and local government facilities. State and local agencies buy finished generic pharmaceuticals in this category for distribution through authorized wholesale channels rather than direct manufacture; the recent MMCAP RFP targets manufacturers and authorized distributors offering comprehensive pricing on identified generic drugs with specific National Drug Codes, requiring submission of detailed product specifications including NDC codes, SKUs, UPCs, strength, dosage form, and packaging configurations. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), and accept pricing flexibility through multiple formats including flat price, net price, or WAC-minus structures. Proposals are due March 26, 2026, with a question cutoff of February 18, 2026; evaluation weights pricing competitiveness at 75 percent, fixed pricing at 10 percent, and compliance, EDI capability, and administrative fee agreement each at 5 percent. Vendors must carry workers' compensation, commercial general liability of $5 million per occurrence, network security and privacy liability of $2 million, and professional liability of $2 million, and all products must have expiration dates at least one year from manufacture with a minimum six-month shelf life.
The code shows activity concentrated in the multistate cooperative purchasing environment, with MMCAP serving participating members across Minnesota and Oregon. MMCAP awards contracts for two-year terms for new responders with optional extensions at MMCAP's discretion, while incumbent vendor amendments align with existing agreement dates through June 30, 2028. The RFP does not disclose specific dollar values or budget ranges, and no set-aside designations or disadvantaged-enterprise restrictions appear in the available documentation. Vendors should expect to pay a 3 percent administrative fee on all contract purchases and face performance penalties of $200 to $1,500 per violation for issues such as late reporting, missed onboarding timelines, or improper class-of-trade denials. All awarded vendors will be provided to authorized wholesalers by May 15, 2026, with resulting agreements effective July 1, 2026.
Quick answers
What is UNSPSC 51111835?
UNSPSC 51111835 is Benorterone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51111835?
UNSPSC 51111835 maps to 1 NIGP code, 26968 Hormones and Synthetic Substitutes.
On GovTribe
See everything under UNSPSC 51111835
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code